Serelaxin: a novel therapy for acute heart failure with a range of hemodynamic and non-hemodynamic actions - Wikidata - awgldk - TriplyDB

Serelaxin: a novel therapy for acute heart failure with a range of hemodynamic and non-hemodynamic actions

Serelaxin: a novel therapy for acute heart failure with a range of hemodynamic and non-hemodynamic actions

http://www.wikidata.org/entity/Q33970136

about

Serelaxin for the treatment of acute heart failure: a review with a focus on end-organ protection Cardiac endothelium-myocyte interaction: clinical opportunities for new heart failure therapies regardless of ejection fraction Recombinant human relaxin-2: (how) can a pregnancy hormone save lives in acute heart failure?Renal impairment and worsening of renal function in acute heart failure: can new therapies help? The potential role of serelaxin.Postoperative management of heart failure in pediatric patients.Acute Heart Failure: Definition, Classification and Epidemiology.Serelaxin in clinical development: past, present and future.MicroRNA and receptor mediated signaling pathways as potential therapeutic targets in heart failure.Serelaxin improves cardiac and renal function in DOCA-salt hypertensive rats.Effects of serelaxin on renal microcirculation in rats under control and high-angiotensin environments.Hormone treatments in congestive heart failure.

P2860

Q26740185-B4AC8EA4-ADA8-462F-92E1-6D536247A623 Q26853363-AC883396-8787-4493-8152-41E1A46704A8 Q38220684-1B2A1F57-851E-4DEB-99CF-09FD1F2E08EA Q38383238-E3BD3665-D211-42FE-9B47-848ACF1F0F35 Q38631238-B6A83D32-CE2E-4D8F-AD20-EC92E01DEE15 Q38635535-71E3FC31-1C32-4C46-B06A-AE168253E1BE Q38778886-08EF0338-F072-435A-989B-F328211F9D1F Q38842507-7A88D8D4-937F-41F2-8654-10A34113E58D Q41547300-B4EBDD3A-20DA-4071-ADF0-FAD212888CD6 Q47619900-58BAFE00-4A4D-469F-B902-6F0085729AA2 Q55514382-D695EC4B-49F1-4D5E-8CFA-DF829C70C4A7

P2860

Serelaxin: a novel therapy for acute heart failure with a range of hemodynamic and non-hemodynamic actions

http://www.wikidata.org/entity/Q33970136

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Serelaxin: a novel therapy for ...... ic and non-hemodynamic actions

@ast

Serelaxin: a novel therapy for ...... ic and non-hemodynamic actions

@en

type

label

Serelaxin: a novel therapy for ...... ic and non-hemodynamic actions

@ast

Serelaxin: a novel therapy for ...... ic and non-hemodynamic actions

@en

prefLabel

Serelaxin: a novel therapy for ...... ic and non-hemodynamic actions

@ast

Serelaxin: a novel therapy for ...... ic and non-hemodynamic actions

@en

P1433

Q33970136-9517A9A6-6094-490F-868A-1F2E9A6DCE75

P1476

Q33970136-8A57BFA9-E081-4EBB-88EF-37EF3DACE260

P2093

Q33970136-4EB86F1F-44F3-4113-8494-2476EDE094C5

P2860

Q33970136-0502F8C6-8342-4764-B046-A7F5F7383559

Q33970136-06CBF364-FB51-41E0-8FFC-B0B49E785C38

Q33970136-0AEE6CC0-8DB8-43F6-837E-6BD286EC6BE3

Q33970136-0E4D90ED-6BD5-4D0E-8E8E-581D4F4F360A

Q33970136-13A0C953-71F8-4EF3-A366-8229DD68DDB4

Q33970136-1A24DA42-C5BA-4888-BB15-4D1E496B22CD

Q33970136-1E543F28-5B50-40B6-BCA1-7C20242A38BC

Q33970136-202CA028-03E6-4A27-ADA4-230B82D53C17

Q33970136-264FCE46-2C9C-422D-B063-DA371A230766

Q33970136-272B7C37-D793-438F-B10E-1CF3F9443B6B

P2888

Q33970136-826F19C6-8BAF-493B-A7B8-1AF9F3B20E26

P304

Q33970136-30C51435-0AC2-460A-B8D1-9900B0420002

P31

Q33970136-31AA9916-13A7-40CA-A794-2ADC3BE4DE84

Q33970136-44238A6A-02B0-48CE-85D6-38EF87D3CEA1

P356

Q33970136-84E81C1F-95A0-411E-9F25-84616494DA04

P433

Q33970136-0CF8A661-7A11-498F-A746-9297454147DF

P478

Q33970136-7F75191B-BCCB-46DE-9AAA-7D12D03B9DB8

P577

Q33970136-DCFF9ABA-D65B-4D28-8FE1-C7649B8A44FF

P5875

Q33970136-1E9D5080-2C77-4F3B-8790-CAC1463BB094

P6179

Q33970136-5F6F28F5-DB1A-4D47-9F90-278B0717431D

P698

Q33970136-61598945-4F6B-4C7F-8BD4-39F044DF905E

P921

Q33970136-41B67042-7C72-4302-94A1-2E5FC41712A6

Q33970136-62DB66D6-BCFC-4352-95C3-BEE8E867DDC7

Q33970136-A697EF98-4A4B-44AC-BA1E-F4DF23737821

Q33970136-BE10E5F7-31BA-49D4-868B-B38A3DF75659

P932

Q33970136-D2DE63B5-C44F-4E60-AB81-D006100F6B14

P356

S40256-014-0069-0

P1433

American journal of cardiovascular drugs

P1476

Serelaxin: a novel therapy for ...... ic and non-hemodynamic actions

@en

P2093

Javier Díez

http://www.w3.org/2001/XMLSchema#string

P2860

Relaxin inhibits renal myofibroblast differentiation via RXFP1, the nitric oxide pathway, and Smad2

Relaxin is a potent renal vasodilator in conscious rats.

Relaxin: review of biology and potential role in treating heart failure.

Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group.

Acute treatment with relaxin protects the kidney against ischaemia/reperfusion injury

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial.

Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial.

Relaxin signals through a RXFP1-pERK-nNOS-NO-cGMP-dependent pathway to up-regulate matrix metalloproteinases: the additional involvement of iNOS.

Novel drug development opportunity for relaxin in acute myocardial infarction: evidences from a swine model.

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.

P2888

s40256-014-0069-0

P304

275-285

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40256-014-0069-0

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2014-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260485582

http://www.w3.org/2001/XMLSchema#string

P6179

1045931879

http://www.w3.org/2001/XMLSchema#string

P698

24590581

http://www.w3.org/2001/XMLSchema#string

P921

P932

4115190

http://www.w3.org/2001/XMLSchema#string